Surgical Robotics Market to Reach US$15.25 Billion by 2033, Growing at 11.3% CAGR | North America Dominates with 43.3% Market Share | DataM Intelligence

Leander, Texas and Tokyo, Japan - Dec 02, 2025
According to DataM Intelligence, the global surgical robotics market reached US$5.84 billion in 2024 and is expected to reach US$15.25 billion by 2033, growing at a CAGR of 11.3% during the forecast period 2025-2033. This robust growth is propelled by increasing adoption of minimally invasive surgery, technological advancements in robotics and AI, growing prevalence of chronic diseases requiring complex procedures, rising demand for precision and consistency in surgery, and favorable reimbursement policies in key markets.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/surgical-robotics-market?jd

Report Details:
• No. of Pages: 180
• Forecast Period: 2025-2033
• Market Size (2024): $5.84 Billion
• Market Size (2033): $15.25 Billion
• Compound Annual Growth Rate: 11.3%
• Regions Covered: Global

Global Recent Developments (Sept-Nov 2025):
✅ November 2025: Intuitive Surgical received FDA 510(k) clearance for its next-generation "da Vinci 5" system featuring enhanced haptic feedback, integrated intraoperative imaging, and AI-powered tissue recognition, significantly reducing procedure time in complex oncology surgeries.
✅ November 2025: A multi-center study in The Lancet demonstrated that AI-integrated robotic spine surgery (using systems like Globus Medical's ExcelsiusGPS®) reduced pedicle screw placement inaccuracies by over 90% and lowered hospital stays by two days, accelerating adoption in neurosurgery.
✅ October 2025: Johnson & Johnson launched its modular "Ottava" robotic system for soft tissue surgery, designed for multi-quadrant access in abdominal procedures, directly challenging Intuitive's market dominance with a more flexible architecture.
✅ October 2025: Medtronic announced the first successful human use of its "HugoTM RAS" system for cardiac ablation procedures, expanding its application beyond general surgery into the high-growth cardiovascular robotics segment.
✅ September 2025: Stryker's Mako SmartRoboticsTM platform achieved a milestone with its one-millionth joint replacement procedure, with new data showing a 25% reduction in revision rates for robotic-assisted knee arthroplasty compared to conventional methods.

Buy Now and Enjoy a 30% Year-End Discount: https://www.datamintelligence.com/buy-now-page?report=surgical-robotics-market

Competitive Landscape
The market features intense competition between established robotic surgery pioneers and new entrants from major medtech companies.

1. Intuitive Surgical maintained dominant market leadership with 65% global market share in robotic surgery systems, expanding its da Vinci platform and reporting 22% revenue growth in 2024-2025.
2. Stryker Corporation captured 15% market share, leading the orthopedic robotics segment with its Mako system and achieving 30% growth through expansion into outpatient joint replacement centers.
3. Johnson & Johnson (via Verb Surgical & Auris Health) secured 8% market share with its Ottava and Monarch platforms, reporting 45% growth as it ramped up commercial launches.
4. Medtronic plc held 7% market share with its HugoTM RAS system, achieving 50% growth through geographic expansion and new surgical indications.
5. Zimmer Biomet led in the competitive knee robotics space with its ROSA® Knee system, holding 5% market share with 25% revenue growth.

Speak to Our Analyst and Get Customization in the Report: https://www.datamintelligence.com/customize/surgical-robotics-market?jd

Segmentation Analysis
By Product Type
• Robotic Surgery Systems represent the capital-intensive core of the market, while Instruments and Accessories drive recurring revenue and are the largest segment by revenue share (over 55% in 2024), growing at 12.5% CAGR. This includes robotic arms, end-effectors, cameras, and disposable instruments that are required for each procedure. The high-margin, recurring nature of this segment ensures stable cash flow for manufacturers and locks in hospital customers through proprietary ecosystems.

By Indication
• General Surgery (including colorectal, bariatric, and oncology) holds the largest share of robotic procedures, driven by the established da Vinci platform. However, Orthopedic Surgery is the fastest-growing segment, fueled by the aging population, high volume of joint replacements, and demonstrable improvements in outcomes and implant longevity with systems like Mako and ROSA.
• Cardiovascular and Neurosurgery are high-growth, high-complexity segments attracting significant R&D investment from new entrants.

By End User
• Hospitals command the dominant share (over 70% in 2024), as they are the primary centers for complex inpatient robotic surgeries. Growth is driven by the need for competitive differentiation, surgical volume consolidation, and value-based care initiatives that reward better outcomes and shorter stays.
• Ambulatory Surgical Centers (ASCs) are the fastest-growing end-user segment, particularly for orthopedic and certain urological procedures, as robotics enable more complex surgeries to move safely to outpatient settings, reducing costs.

Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription?jd

Regional Analysis:
North America dominated the global surgical robotics market with the highest share of 43.3% in 2024, driven by high healthcare expenditure, favorable CMS reimbursement for robotic procedures, a high concentration of early-adopter surgeons and hospitals, strong presence of leading manufacturers, and a well-established ecosystem for surgical training and innovation.

Asia-Pacific is a key growth engine for the global surgical robotics market with a market share of 23.5% in 2024 and is projected to be the fastest-growing region. Growth is fueled by improving healthcare infrastructure, rising medical tourism (especially in South Korea, Thailand, India), growing acceptance of advanced medical technology, increasing investments by global players to tap into the large patient population, and supportive government initiatives in countries like China and Japan.

Market Trends & Drivers
The Surgical Robotics Market is experiencing robust, innovation-driven growth. Key trends include the shift from monolithic systems to modular, specialized platforms for different surgical domains; the integration of AI and machine learning for predictive analytics, surgical guidance, and automation of routine tasks; expansion into outpatient and ASC settings; development of miniaturized and single-port robots for reduced invasiveness; and intense competition leading to pricing pressure and new business models like robotics-as-a-service (RaaS). The clinical evidence proving superior outcomes, economic pressures for efficiency, and technological convergence are significantly contributing to market growth.

Related Reports:
1. Minimally Invasive Surgery Devices Market - https://www.datamintelligence.com/research-report/minimally-invasive-surgery-devices-market?jd
2. Medical Robotics Market - https://www.datamintelligence.com/research-report/medical-robotics-market?jd
3. Orthopedic Devices Market - https://www.datamintelligence.com/research-report/orthopedic-devices-market?jd

Contact Us:
Sai Kiran
DataM Intelligence 4market Research LLP
Phone: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specialises in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.